Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
05.12.24On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin
05.12.24Novartis' latest attempt to fend off MSN's Entresto generic falls short on appeal
05.12.24AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell lung cancer
05.12.24GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal
05.12.24Amgen rolls out $1B investment to build new drug substance plant in NC's biopharma hotbed
05.12.24AstraZeneca chided by marketing watchdog after complainant aims allegations at senior staff
05.12.24For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
05.12.24FDA signs off on Merus' first-in-class NRG1+ cancer drug Bizengri after brief delay
04.12.24Novo Nordisk keeps manufacturing expansion spree rolling with plans for $400M quality hub in Denmark
04.12.24AstraZeneca's Enhertu and Akeso's bispecifics win national coverage in China as CAR-T therapies miss out again
04.12.24Klick Health uses AI to orchestrate 'Holiday Hugs' after survey shows scarcity in year-round embraces
04.12.24With AstraZeneca exec under investigation in China, company names Reic new international chief
04.12.24Sumitomo brings together Gemtesa 'Go-Getters' to discuss overactive bladder symptoms
04.12.24Novavax scores $200M as it hands over keys to Czech production plant-along with 300 employees-to Novo Nordisk
04.12.24Eli Lilly's Zepbound defeats Novo Nordisk's Wegovy in head-to-head weight loss trial
03.12.24Coherus sells its last biosimilar Udenyca to Intas for up to $558M as company homes in on novel cancer meds
03.12.24IRA price negotiations and M&A among topics to watch after 'Republican Red Wave,' analyst group says
03.12.24CSL Seqirus inks bird flu vaccine supply pact with UK after similar deals in US, Europe
03.12.24Reckitt shells out $200M to expand its Mucinex production site in North Carolina
03.12.24Lil Jon delivers scat rap, duets with singing toilet to promote Exact Sciences' cancer kit
03.12.24Agenus to offer CDMO services as part of its latest reorganization
03.12.24RFK Jr. could 'cost lives in this country' if he pursues changes to US vaccine policy, Gottlieb says
02.12.24After temporary reprieve, Advanz Pharma's liver med Ocaliva loses marketing nod in Europe
02.12.24Quantoom, Univercells and Fiocruz ink collaboration to bolster RNA-based vaccines in Brazil and beyond
02.12.24FDA considers 'regulatory action' for bluebird's Skysona after blood cancer reports